Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 When Is a Rare Disease Not so Rare? Implications for Medical Nutrition Therapy.

Literature DB >> 27053929

When Is a Rare Disease Not so Rare? Implications for Medical Nutrition Therapy.

Jeffrey Bland¹.

Abstract

Year: 2016 PMID： 27053929 PMCID： PMC4818062

Source DB: PubMed Journal: Integr Med (Encinitas) ISSN： 1546-993X

Keyword Cloud
References

× No keyword cloud information.

20 in total

1. Treatments for rare diseases: molybdenum cofactor deficiency.

Authors: Bridget Wilcken
Journal: Lancet Date: 2015-09-03 Impact factor: 79.321

2. Taurine decreases fecal fatty acid and sterol excretion in cystic fibrosis. A randomized double-blind trial.

Authors: L J Smith; F Lacaille; G Lepage; N Ronco; A Lamarre; C C Roy
Journal: Am J Dis Child Date: 1991-12

3. A new syndrome of bile acid deficiency-a possible synthetic defect.

Authors: G K Powell; L A Jones; J Richardson
Journal: J Pediatr Date: 1973-11 Impact factor: 4.406

4. Characterization of the molybdenum cofactor of sulfite oxidase, xanthine, oxidase, and nitrate reductase. Identification of a pteridine as a structural component.

Authors: J L Johnson; B E Hainline; K V Rajagopalan
Journal: J Biol Chem Date: 1980-03-10 Impact factor: 5.157

5. Fat-Modified Enteral Formula Improves Feeding Tolerance in Critically Ill Patients: A Multicenter, Single-Blind, Randomized Controlled Trial.

Authors: Chunfang Qiu; Chuanxi Chen; Weixing Zhang; Qiuye Kou; Shengnan Wu; Lixin Zhou; Jiyun Liu; Gang Ma; Juan Chen; Minying Chen; Hua Luo; Xiaofei Zhang; Jianbo Lai; Zhihui Yu; Xiaochun Yu; Wei Liao; Xiangdong Guan; Bin Ouyang
Journal: JPEN J Parenter Enteral Nutr Date: 2015-09-08 Impact factor: 4.016

When Is a Rare Disease Not so Rare? Implications for Medical Nutrition Therapy.

1. Treatments for rare diseases: molybdenum cofactor deficiency.

2. Taurine decreases fecal fatty acid and sterol excretion in cystic fibrosis. A randomized double-blind trial.

3. A new syndrome of bile acid deficiency-a possible synthetic defect.

4. Characterization of the molybdenum cofactor of sulfite oxidase, xanthine, oxidase, and nitrate reductase. Identification of a pteridine as a structural component.

5. Fat-Modified Enteral Formula Improves Feeding Tolerance in Critically Ill Patients: A Multicenter, Single-Blind, Randomized Controlled Trial.

6. Molybdenum metabolism: stable isotope studies in infancy.

Review 7. Distribution and pathophysiologic role of molybdenum-containing enzymes.

8. Zinc binding: a difference between human and bovine milk.

Review 9. Mutations in the molybdenum cofactor biosynthetic genes MOCS1, MOCS2, and GEPH.

10. Phenylketonuria: nutritional advances and challenges.